Dunbar Pharma’s Leah Fletcher discusses Ireland’s potential in the cannabinoid therapy landscape and how breaking tradition is a critical step towards advancement.
Read more: The CEO innovating in Ireland’s ‘controlled and cautious’ medical cannabis space